| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 51 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 50 |
| 2 | TACROLIMUS OINTMENT 0.1% | 50 |
| 3 | PREDNISONE | 22 |
| 4 | MYCOPHENOLATE MOFETIL | 18 |
| 5 | EVEROLIMUS | 14 |
| 6 | EVEROLIMUS TABLETS | 14 |
| 7 | MYCOPHENILIC ACID | 14 |
| 8 | MYCOPHENOLIC ACID | 14 |
| 9 | METHYLPREDNISOLONE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRINCIDOFOVIR | 1 | 0.0072 |
| 1 | EVEROLIMUS TABLETS | 14 | 0.0008 |
| 2 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 3 | FEBUXOSTAT TABLETS 40 MG | 7 | 0.0007 |
| 4 | MYCOPHENILIC ACID | 14 | 0.0007 |
| 5 | BELATACEPT | 3 | 0.0006 |
| 6 | MYCOPHENOLIC ACID | 14 | 0.0004 |
| 7 | FEBUXOSTAT | 7 | 0.0004 |
| 8 | TACROLIMUS OINTMENT 0.1% | 50 | 0.0004 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 50 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 14 | 0.0007 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | Polyene Antifungal [EPC] | 3 | 0.0001 |
| 6 | Histamine-2 Receptor Antagonist [EPC] | 7 | 0.0001 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 7 | 0.0000 |
| 8 | Corticosteroid [EPC] | 36 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 14 | 0.0000 |